MYC Releases Early Reprogrammed Human Cells from Proliferation Pause via Retinoblastoma Protein Inhibition

Tim Rand(Gladstone Institutes), Kenta Sutou(Kyoto University), Koji Tanabe(Stanford University), Daeun Jeong(Gladstone Institutes), Masaki Nomura(Kyoto University), Fumiyo Kitaoka(Kyoto University), Emi Tomoda(Gladstone Institutes), Megumi Narita(Kyoto University), Michiko Nakamura(Kyoto University), Masahiro Nakamura(Kyoto University), Akira Watanabe(Kyoto University), Eric Rulifson(Stanford University), Shinya Yamanaka(Gladstone Institutes), Kazutoshi Takahashi(Gladstone Institutes)
Cell Reports
April 1, 2018
Cited by 33Open Access
Full Text

Abstract

Here, we report that MYC rescues early human cells undergoing reprogramming from a proliferation pause induced by OCT3/4, SOX2, and KLF4 (OSK). We identified ESRG as a marker of early reprogramming cells that is expressed as early as day 3 after OSK induction. On day 4, ESRG positive (+) cells converted to a TRA-1-60 (+) intermediate state. These early ESRG (+) or TRA-1-60 (+) cells showed a proliferation pause due to increased p16INK4A and p21 and decreased endogenous MYC caused by OSK. Exogenous MYC did not enhance the appearance of initial reprogramming cells but instead reactivated their proliferation and improved reprogramming efficiency. MYC increased expression of LIN41, which potently suppressed p21 post-transcriptionally. MYC suppressed p16 INK4A. These changes inactivated retinoblastoma protein (RB) and reactivated proliferation. The RB-regulated proliferation pause does not occur in immortalized fibroblasts, leading to high reprogramming efficiency even without exogenous MYC.


Related Papers

No related papers found

Powered by citation graph analysis